{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:35:33Z","timestamp":1770507333960,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.vaccine.2007.09.026","type":"journal-article","created":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T18:00:10Z","timestamp":1191261610000},"page":"8077-8084","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of ChimeriVax Japanese Encephalitis Virus envelope for T-cell epitopes and comparison to circulating strain sequences"],"prefix":"10.1016","volume":"25","author":[{"given":"Anne S.","family":"De Groot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Moise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshad","family":"Guirakhoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Monath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.09.026_bib1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/viro.1999.9695","article-title":"Immunogenicity, genetic stability and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax\u2122-JE) as a live, attenuated vaccine candidate against Japanese encephalitis","volume":"257","author":"Guirakhoo","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.09.026_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/clinids\/24.2.265","article-title":"Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine","volume":"24","author":"Berg","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.09.026_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0163-4453(96)91281-5","article-title":"Adverse reactions to Japanese encephalitis vaccine in travellers","volume":"32","author":"Nothdurft","year":"1996","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2007.09.026_bib4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/jnnp.59.3.316","article-title":"Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains)","volume":"59","author":"Ohtaki","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.vaccine.2007.09.026_bib5","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0264-410X(99)00403-X","article-title":"Case\u2013control study of allergic reactions to Japanese encephalitis vaccine","volume":"18","author":"Plesner","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.026_bib6","series-title":"Vaccines","first-page":"671","article-title":"Japanese encephalitis vaccines","author":"Tsai","year":"1994"},{"key":"10.1016\/j.vaccine.2007.09.026_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5694\/j.1326-5377.1996.tb124960.x","article-title":"An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995","volume":"165","author":"Hanna","year":"1996","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2007.09.026_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.5694\/j.1326-5377.1999.tb127878.x","article-title":"Japanese encephalitis in north Queensland, Australia, 1998","volume":"170","author":"Hanna","year":"1999","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2007.09.026_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01321074","article-title":"Arboviruses causing human disease in the Australasian zoogeographic region","volume":"136","author":"Mackenzie","year":"1994","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2007.09.026_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0264-410X(00)00039-6","article-title":"Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus","volume":"18","author":"Tsarev","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.026_bib11","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/JVI.77.5.3091-3098.2003","article-title":"Origin and evolution of Japanese Encephalitis Virus in Southeast Asia","volume":"77","author":"Solomon","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.09.026_bib12","first-page":"941","article-title":"Protection of SA14-14-2 live attenuated Japanese encephalitis vaccine against the wild-type JE viruses","volume":"116","author":"Jia","year":"2003","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.vaccine.2007.09.026_bib13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines","volume":"319","author":"Hoke","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.09.026_bib14","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/infdis\/161.5.878","article-title":"Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US citizens","volume":"161","author":"Poland","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.09.026_bib15","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1016\/j.vaccine.2004.03.027","article-title":"Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine","volume":"22","author":"Beasley","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.026_bib16","first-page":"139","article-title":"An interactive web site providing MHC ligand predictions: application to HIV research","volume":"7","author":"De Groot","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.vaccine.2007.09.026_bib17","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/S0264-410X(98)00173-X","article-title":"Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix","volume":"16","author":"Schafer","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.026_bib18","first-page":"71","article-title":"Modelling the immunogenicity of therapeutic proteins using T-cell epitope mapping","volume":"112","author":"De Groot","year":"2003","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2007.09.026_bib19","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.vaccine.2005.01.097","article-title":"HIV vaccine development by computer assisted design: the GAIA vaccine","volume":"23","author":"De Groot","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.026_bib20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0264-410X(94)00014-E","article-title":"Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences","volume":"13","author":"Meister","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.026_bib21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/aid.1996.12.593","article-title":"Prediction of HIV peptide epitopes by a novel algorithm","volume":"12","author":"Roberts","year":"1996","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.vaccine.2007.09.026_bib22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0968-0004(98)01285-7","article-title":"Multiple sequence alignment with Clustal X","volume":"23","author":"Jeanmougin","year":"1998","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.vaccine.2007.09.026_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1089\/aid.1997.13.529","article-title":"An interactive web site providing MHC ligand predictions: application to HIV research","volume":"13","author":"De Groot","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.vaccine.2007.09.026_bib24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/JVI.75.2.934-942.2001","article-title":"Molecular basis for attenuation of neurovirulence of a yellow fever\/Japanese Encephalitis (ChimeriVax-JE) viral vaccine","volume":"75","author":"Arroyo","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.09.026_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1146\/annurev.iy.12.040194.004423","article-title":"Towards a vaccine for AIDS: the emergence of immunobiology-based vaccine development","volume":"12","author":"Cease","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2007.09.026_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/14760584.3.1.59","article-title":"Genome-derived vaccines","volume":"3","author":"De Groot","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2007.09.026_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/088922201750236988","article-title":"An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected thais","volume":"17","author":"Bond","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.vaccine.2007.09.026_bib28","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1016\/S0264-410X(03)00390-6","article-title":"Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach","volume":"21","author":"De Groot","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.026_bib29","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.vaccine.2005.01.059","article-title":"Developing an epitope-driven tuberculosis (TB) vaccine","volume":"23","author":"De Groot","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.09.026_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2174\/156652407780831584","article-title":"Vaccine Development: A streamlined approach using immunoinformatics, ELISpot assays and HLA transgenic mice","volume":"7","author":"McMurry","year":"2007","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.vaccine.2007.09.026_bib31","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/hep.510300435","article-title":"Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development","volume":"30","author":"Lamonaca","year":"1999","journal-title":"Hepatology"},{"issue":"16","key":"10.1016\/j.vaccine.2007.09.026_bib32","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/j.vaccine.2007.01.039","article-title":"Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine","volume":"25","author":"McMurry","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.026_bib33","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1172\/JCI118287","article-title":"HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus Identification of multiple epitopes and characterization of patterns of cytokine release","volume":"96","author":"Koziel","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2007.09.026_bib34","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.4049\/jimmunol.154.6.2733","article-title":"CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1","volume":"154","author":"Shirai","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.09.026_bib35","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/1521-4141(200105)31:5<1438::AID-IMMU1438>3.0.CO;2-2","article-title":"Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients","volume":"31","author":"Godkin","year":"2001","journal-title":"Eur J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07010304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07010304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T08:57:36Z","timestamp":1684054656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07010304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":35,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0264410X07010304"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.09.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}